The American Society of Haematology (ASH) Research Collaborative has launched an international registry of patients who test positive for COVID-19 and have been or are currently being treated for a hematologic malignancy. The registry said there was an urgent need to rapidly collect and disseminate surveillance data on the natural history of these patients. “Early ...
COVID-19 registry set up for haematologic malignancies: Prof. Jeff Szer
By Mardi Chapman
7 Apr 2020